Advanced Science-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2233419, encodeId=12af2233419f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：10.10 complete accept 10.10 pay the APC 10.12 manuscript in production 同时要求我修改下supplementary figure在文中的标注然后迄今都还没有proof，投稿系统一直显示in production. 有遇到相同情况的同行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Sun Oct 27 13:12:31 CST 2024, time=2024-10-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262915, encodeId=0e0222629150f, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Wed Apr 30 16:36:01 CST 2025, time=17小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232303, encodeId=c3882232303bb, content=偏重的研究方向：医学 经验分享：请问大佬们这个杂志外审后拒稿都是拒稿重投吗还是一部分彻底拒稿一部分拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Tue Oct 22 00:22:52 CST 2024, time=2024-10-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2225854, encodeId=5abe22258544d, content=请问各位大佬送审后拒稿概率大吗o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Sat Sep 14 16:14:14 CST 2024, time=2024-09-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206850, encodeId=9835220685019, content=请问拒稿重投邮件都写的是什么啊，We appreciate you considering Advanced Science and regret that we are unable to provide a more positive outcome at this stage, but we hope the reviewer comments will help you to improve your manuscript for resubmission to Advanced Science. 我也不确定这是不是拒稿重投，但投稿系统确实是拒稿了~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=650b5421607, createdName=SCI小青椒, createdTime=Mon May 27 14:26:15 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2218556, encodeId=23ab22185563d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两正一负意见，拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72939412153, createdName=ms1000001167055324, createdTime=Mon Aug 05 14:11:46 CST 2024, time=2024-08-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230217, encodeId=11ee223021eb8, content=偏重的研究方向：医学;基础研究;肠道菌群 经验分享：想请问一下拒稿重投的接受可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Thu Oct 10 20:14:53 CST 2024, time=2024-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2251519, encodeId=cab42251519f4, content=请问有友友是被拒稿申诉以后给大修机会的吗，中稿的机会大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6829440210, createdName=ms2000000449821444, createdTime=Tue Feb 11 21:51:51 CST 2025, time=2025-02-11, status=1, ipAttribution=江苏省)]

2024-10-27 研骨小虫冲来自浙江省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：生命科学
经验分享：10.10 complete accept 10.10 pay the APC 10.12 manuscript in production 同时要求我修改下supplementary figure在文中的标注然后迄今都还没有proof，投稿系统一直显示in production. 有遇到相同情况的同行吗？

47 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233419, encodeId=12af2233419f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：10.10 complete accept 10.10 pay the APC 10.12 manuscript in production 同时要求我修改下supplementary figure在文中的标注然后迄今都还没有proof，投稿系统一直显示in production. 有遇到相同情况的同行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Sun Oct 27 13:12:31 CST 2024, time=2024-10-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262915, encodeId=0e0222629150f, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Wed Apr 30 16:36:01 CST 2025, time=17小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232303, encodeId=c3882232303bb, content=偏重的研究方向：医学 经验分享：请问大佬们这个杂志外审后拒稿都是拒稿重投吗还是一部分彻底拒稿一部分拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Tue Oct 22 00:22:52 CST 2024, time=2024-10-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2225854, encodeId=5abe22258544d, content=请问各位大佬送审后拒稿概率大吗o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Sat Sep 14 16:14:14 CST 2024, time=2024-09-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206850, encodeId=9835220685019, content=请问拒稿重投邮件都写的是什么啊，We appreciate you considering Advanced Science and regret that we are unable to provide a more positive outcome at this stage, but we hope the reviewer comments will help you to improve your manuscript for resubmission to Advanced Science. 我也不确定这是不是拒稿重投，但投稿系统确实是拒稿了~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=650b5421607, createdName=SCI小青椒, createdTime=Mon May 27 14:26:15 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2218556, encodeId=23ab22185563d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两正一负意见，拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72939412153, createdName=ms1000001167055324, createdTime=Mon Aug 05 14:11:46 CST 2024, time=2024-08-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230217, encodeId=11ee223021eb8, content=偏重的研究方向：医学;基础研究;肠道菌群 经验分享：想请问一下拒稿重投的接受可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Thu Oct 10 20:14:53 CST 2024, time=2024-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2251519, encodeId=cab42251519f4, content=请问有友友是被拒稿申诉以后给大修机会的吗，中稿的机会大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6829440210, createdName=ms2000000449821444, createdTime=Tue Feb 11 21:51:51 CST 2025, time=2025-02-11, status=1, ipAttribution=江苏省)]

17小时前 124d4ad8m98暂无昵称来自广东省

前往app查看评论内容

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2233419, encodeId=12af2233419f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：10.10 complete accept 10.10 pay the APC 10.12 manuscript in production 同时要求我修改下supplementary figure在文中的标注然后迄今都还没有proof，投稿系统一直显示in production. 有遇到相同情况的同行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Sun Oct 27 13:12:31 CST 2024, time=2024-10-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262915, encodeId=0e0222629150f, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Wed Apr 30 16:36:01 CST 2025, time=17小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232303, encodeId=c3882232303bb, content=偏重的研究方向：医学 经验分享：请问大佬们这个杂志外审后拒稿都是拒稿重投吗还是一部分彻底拒稿一部分拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Tue Oct 22 00:22:52 CST 2024, time=2024-10-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2225854, encodeId=5abe22258544d, content=请问各位大佬送审后拒稿概率大吗o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Sat Sep 14 16:14:14 CST 2024, time=2024-09-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206850, encodeId=9835220685019, content=请问拒稿重投邮件都写的是什么啊，We appreciate you considering Advanced Science and regret that we are unable to provide a more positive outcome at this stage, but we hope the reviewer comments will help you to improve your manuscript for resubmission to Advanced Science. 我也不确定这是不是拒稿重投，但投稿系统确实是拒稿了~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=650b5421607, createdName=SCI小青椒, createdTime=Mon May 27 14:26:15 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2218556, encodeId=23ab22185563d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两正一负意见，拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72939412153, createdName=ms1000001167055324, createdTime=Mon Aug 05 14:11:46 CST 2024, time=2024-08-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230217, encodeId=11ee223021eb8, content=偏重的研究方向：医学;基础研究;肠道菌群 经验分享：想请问一下拒稿重投的接受可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Thu Oct 10 20:14:53 CST 2024, time=2024-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2251519, encodeId=cab42251519f4, content=请问有友友是被拒稿申诉以后给大修机会的吗，中稿的机会大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6829440210, createdName=ms2000000449821444, createdTime=Tue Feb 11 21:51:51 CST 2025, time=2025-02-11, status=1, ipAttribution=江苏省)]

2024-03-22 122aa381m91(暂无昵称) 来自北京

审稿速度:12.0 | 投稿命中率:25.0
偏重的研究方向：基础医学
经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。

151 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233419, encodeId=12af2233419f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：10.10 complete accept 10.10 pay the APC 10.12 manuscript in production 同时要求我修改下supplementary figure在文中的标注然后迄今都还没有proof，投稿系统一直显示in production. 有遇到相同情况的同行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Sun Oct 27 13:12:31 CST 2024, time=2024-10-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262915, encodeId=0e0222629150f, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Wed Apr 30 16:36:01 CST 2025, time=17小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232303, encodeId=c3882232303bb, content=偏重的研究方向：医学 经验分享：请问大佬们这个杂志外审后拒稿都是拒稿重投吗还是一部分彻底拒稿一部分拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Tue Oct 22 00:22:52 CST 2024, time=2024-10-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2225854, encodeId=5abe22258544d, content=请问各位大佬送审后拒稿概率大吗o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Sat Sep 14 16:14:14 CST 2024, time=2024-09-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206850, encodeId=9835220685019, content=请问拒稿重投邮件都写的是什么啊，We appreciate you considering Advanced Science and regret that we are unable to provide a more positive outcome at this stage, but we hope the reviewer comments will help you to improve your manuscript for resubmission to Advanced Science. 我也不确定这是不是拒稿重投，但投稿系统确实是拒稿了~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=650b5421607, createdName=SCI小青椒, createdTime=Mon May 27 14:26:15 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2218556, encodeId=23ab22185563d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两正一负意见，拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72939412153, createdName=ms1000001167055324, createdTime=Mon Aug 05 14:11:46 CST 2024, time=2024-08-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230217, encodeId=11ee223021eb8, content=偏重的研究方向：医学;基础研究;肠道菌群 经验分享：想请问一下拒稿重投的接受可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Thu Oct 10 20:14:53 CST 2024, time=2024-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2251519, encodeId=cab42251519f4, content=请问有友友是被拒稿申诉以后给大修机会的吗，中稿的机会大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6829440210, createdName=ms2000000449821444, createdTime=Tue Feb 11 21:51:51 CST 2025, time=2025-02-11, status=1, ipAttribution=江苏省)]

2024-10-22 congratulation 123 来自辽宁省

偏重的研究方向：医学
经验分享：请问大佬们这个杂志外审后拒稿都是拒稿重投吗还是一部分彻底拒稿一部分拒稿重投

41 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233419, encodeId=12af2233419f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：10.10 complete accept 10.10 pay the APC 10.12 manuscript in production 同时要求我修改下supplementary figure在文中的标注然后迄今都还没有proof，投稿系统一直显示in production. 有遇到相同情况的同行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Sun Oct 27 13:12:31 CST 2024, time=2024-10-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262915, encodeId=0e0222629150f, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Wed Apr 30 16:36:01 CST 2025, time=17小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232303, encodeId=c3882232303bb, content=偏重的研究方向：医学 经验分享：请问大佬们这个杂志外审后拒稿都是拒稿重投吗还是一部分彻底拒稿一部分拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Tue Oct 22 00:22:52 CST 2024, time=2024-10-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2225854, encodeId=5abe22258544d, content=请问各位大佬送审后拒稿概率大吗o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Sat Sep 14 16:14:14 CST 2024, time=2024-09-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206850, encodeId=9835220685019, content=请问拒稿重投邮件都写的是什么啊，We appreciate you considering Advanced Science and regret that we are unable to provide a more positive outcome at this stage, but we hope the reviewer comments will help you to improve your manuscript for resubmission to Advanced Science. 我也不确定这是不是拒稿重投，但投稿系统确实是拒稿了~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=650b5421607, createdName=SCI小青椒, createdTime=Mon May 27 14:26:15 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2218556, encodeId=23ab22185563d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两正一负意见，拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72939412153, createdName=ms1000001167055324, createdTime=Mon Aug 05 14:11:46 CST 2024, time=2024-08-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230217, encodeId=11ee223021eb8, content=偏重的研究方向：医学;基础研究;肠道菌群 经验分享：想请问一下拒稿重投的接受可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Thu Oct 10 20:14:53 CST 2024, time=2024-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2251519, encodeId=cab42251519f4, content=请问有友友是被拒稿申诉以后给大修机会的吗，中稿的机会大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6829440210, createdName=ms2000000449821444, createdTime=Tue Feb 11 21:51:51 CST 2025, time=2025-02-11, status=1, ipAttribution=江苏省)]

2024-09-14 congratulation 123 来自辽宁省

请问各位大佬送审后拒稿概率大吗o(╥﹏╥)o

48 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233419, encodeId=12af2233419f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：10.10 complete accept 10.10 pay the APC 10.12 manuscript in production 同时要求我修改下supplementary figure在文中的标注然后迄今都还没有proof，投稿系统一直显示in production. 有遇到相同情况的同行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Sun Oct 27 13:12:31 CST 2024, time=2024-10-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262915, encodeId=0e0222629150f, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Wed Apr 30 16:36:01 CST 2025, time=17小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232303, encodeId=c3882232303bb, content=偏重的研究方向：医学 经验分享：请问大佬们这个杂志外审后拒稿都是拒稿重投吗还是一部分彻底拒稿一部分拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Tue Oct 22 00:22:52 CST 2024, time=2024-10-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2225854, encodeId=5abe22258544d, content=请问各位大佬送审后拒稿概率大吗o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Sat Sep 14 16:14:14 CST 2024, time=2024-09-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206850, encodeId=9835220685019, content=请问拒稿重投邮件都写的是什么啊，We appreciate you considering Advanced Science and regret that we are unable to provide a more positive outcome at this stage, but we hope the reviewer comments will help you to improve your manuscript for resubmission to Advanced Science. 我也不确定这是不是拒稿重投，但投稿系统确实是拒稿了~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=650b5421607, createdName=SCI小青椒, createdTime=Mon May 27 14:26:15 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2218556, encodeId=23ab22185563d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两正一负意见，拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72939412153, createdName=ms1000001167055324, createdTime=Mon Aug 05 14:11:46 CST 2024, time=2024-08-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230217, encodeId=11ee223021eb8, content=偏重的研究方向：医学;基础研究;肠道菌群 经验分享：想请问一下拒稿重投的接受可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Thu Oct 10 20:14:53 CST 2024, time=2024-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2251519, encodeId=cab42251519f4, content=请问有友友是被拒稿申诉以后给大修机会的吗，中稿的机会大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6829440210, createdName=ms2000000449821444, createdTime=Tue Feb 11 21:51:51 CST 2025, time=2025-02-11, status=1, ipAttribution=江苏省)]

2024-05-27 SCI小青椒来自辽宁省

请问拒稿重投邮件都写的是什么啊，We appreciate you considering Advanced Science and regret that we are unable to provide a more positive outcome at this stage, but we hope the reviewer comments will help you to improve your manuscript for resubmission to Advanced Science.
我也不确定这是不是拒稿重投，但投稿系统确实是拒稿了~~

0 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233419, encodeId=12af2233419f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：10.10 complete accept 10.10 pay the APC 10.12 manuscript in production 同时要求我修改下supplementary figure在文中的标注然后迄今都还没有proof，投稿系统一直显示in production. 有遇到相同情况的同行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Sun Oct 27 13:12:31 CST 2024, time=2024-10-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262915, encodeId=0e0222629150f, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Wed Apr 30 16:36:01 CST 2025, time=17小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232303, encodeId=c3882232303bb, content=偏重的研究方向：医学 经验分享：请问大佬们这个杂志外审后拒稿都是拒稿重投吗还是一部分彻底拒稿一部分拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Tue Oct 22 00:22:52 CST 2024, time=2024-10-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2225854, encodeId=5abe22258544d, content=请问各位大佬送审后拒稿概率大吗o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Sat Sep 14 16:14:14 CST 2024, time=2024-09-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206850, encodeId=9835220685019, content=请问拒稿重投邮件都写的是什么啊，We appreciate you considering Advanced Science and regret that we are unable to provide a more positive outcome at this stage, but we hope the reviewer comments will help you to improve your manuscript for resubmission to Advanced Science. 我也不确定这是不是拒稿重投，但投稿系统确实是拒稿了~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=650b5421607, createdName=SCI小青椒, createdTime=Mon May 27 14:26:15 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2218556, encodeId=23ab22185563d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两正一负意见，拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72939412153, createdName=ms1000001167055324, createdTime=Mon Aug 05 14:11:46 CST 2024, time=2024-08-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230217, encodeId=11ee223021eb8, content=偏重的研究方向：医学;基础研究;肠道菌群 经验分享：想请问一下拒稿重投的接受可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Thu Oct 10 20:14:53 CST 2024, time=2024-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2251519, encodeId=cab42251519f4, content=请问有友友是被拒稿申诉以后给大修机会的吗，中稿的机会大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6829440210, createdName=ms2000000449821444, createdTime=Tue Feb 11 21:51:51 CST 2025, time=2025-02-11, status=1, ipAttribution=江苏省)]

2024-08-05 ms1000001167055324 来自浙江省

审稿速度:1.0 | 投稿命中率:25.0
经验分享：两正一负意见，拒稿重投

196 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233419, encodeId=12af2233419f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：10.10 complete accept 10.10 pay the APC 10.12 manuscript in production 同时要求我修改下supplementary figure在文中的标注然后迄今都还没有proof，投稿系统一直显示in production. 有遇到相同情况的同行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Sun Oct 27 13:12:31 CST 2024, time=2024-10-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262915, encodeId=0e0222629150f, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Wed Apr 30 16:36:01 CST 2025, time=17小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232303, encodeId=c3882232303bb, content=偏重的研究方向：医学 经验分享：请问大佬们这个杂志外审后拒稿都是拒稿重投吗还是一部分彻底拒稿一部分拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Tue Oct 22 00:22:52 CST 2024, time=2024-10-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2225854, encodeId=5abe22258544d, content=请问各位大佬送审后拒稿概率大吗o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Sat Sep 14 16:14:14 CST 2024, time=2024-09-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206850, encodeId=9835220685019, content=请问拒稿重投邮件都写的是什么啊，We appreciate you considering Advanced Science and regret that we are unable to provide a more positive outcome at this stage, but we hope the reviewer comments will help you to improve your manuscript for resubmission to Advanced Science. 我也不确定这是不是拒稿重投，但投稿系统确实是拒稿了~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=650b5421607, createdName=SCI小青椒, createdTime=Mon May 27 14:26:15 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2218556, encodeId=23ab22185563d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两正一负意见，拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72939412153, createdName=ms1000001167055324, createdTime=Mon Aug 05 14:11:46 CST 2024, time=2024-08-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230217, encodeId=11ee223021eb8, content=偏重的研究方向：医学;基础研究;肠道菌群 经验分享：想请问一下拒稿重投的接受可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Thu Oct 10 20:14:53 CST 2024, time=2024-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2251519, encodeId=cab42251519f4, content=请问有友友是被拒稿申诉以后给大修机会的吗，中稿的机会大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6829440210, createdName=ms2000000449821444, createdTime=Tue Feb 11 21:51:51 CST 2025, time=2025-02-11, status=1, ipAttribution=江苏省)]

2024-10-10 ms4000000919063399

偏重的研究方向：医学;基础研究;肠道菌群
经验分享：想请问一下拒稿重投的接受可能性大吗

47 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233419, encodeId=12af2233419f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：10.10 complete accept 10.10 pay the APC 10.12 manuscript in production 同时要求我修改下supplementary figure在文中的标注然后迄今都还没有proof，投稿系统一直显示in production. 有遇到相同情况的同行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Sun Oct 27 13:12:31 CST 2024, time=2024-10-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262915, encodeId=0e0222629150f, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Wed Apr 30 16:36:01 CST 2025, time=17小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232303, encodeId=c3882232303bb, content=偏重的研究方向：医学 经验分享：请问大佬们这个杂志外审后拒稿都是拒稿重投吗还是一部分彻底拒稿一部分拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Tue Oct 22 00:22:52 CST 2024, time=2024-10-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2225854, encodeId=5abe22258544d, content=请问各位大佬送审后拒稿概率大吗o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Sat Sep 14 16:14:14 CST 2024, time=2024-09-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206850, encodeId=9835220685019, content=请问拒稿重投邮件都写的是什么啊，We appreciate you considering Advanced Science and regret that we are unable to provide a more positive outcome at this stage, but we hope the reviewer comments will help you to improve your manuscript for resubmission to Advanced Science. 我也不确定这是不是拒稿重投，但投稿系统确实是拒稿了~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=650b5421607, createdName=SCI小青椒, createdTime=Mon May 27 14:26:15 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2218556, encodeId=23ab22185563d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两正一负意见，拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72939412153, createdName=ms1000001167055324, createdTime=Mon Aug 05 14:11:46 CST 2024, time=2024-08-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230217, encodeId=11ee223021eb8, content=偏重的研究方向：医学;基础研究;肠道菌群 经验分享：想请问一下拒稿重投的接受可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Thu Oct 10 20:14:53 CST 2024, time=2024-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2251519, encodeId=cab42251519f4, content=请问有友友是被拒稿申诉以后给大修机会的吗，中稿的机会大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6829440210, createdName=ms2000000449821444, createdTime=Tue Feb 11 21:51:51 CST 2025, time=2025-02-11, status=1, ipAttribution=江苏省)]

2024-05-18 1208f9b9m90暂无昵称来自北京

想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？

93 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233419, encodeId=12af2233419f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生命科学 经验分享：10.10 complete accept 10.10 pay the APC 10.12 manuscript in production 同时要求我修改下supplementary figure在文中的标注然后迄今都还没有proof，投稿系统一直显示in production. 有遇到相同情况的同行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Sun Oct 27 13:12:31 CST 2024, time=2024-10-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262915, encodeId=0e0222629150f, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Wed Apr 30 16:36:01 CST 2025, time=17小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232303, encodeId=c3882232303bb, content=偏重的研究方向：医学 经验分享：请问大佬们这个杂志外审后拒稿都是拒稿重投吗还是一部分彻底拒稿一部分拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Tue Oct 22 00:22:52 CST 2024, time=2024-10-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2225854, encodeId=5abe22258544d, content=请问各位大佬送审后拒稿概率大吗o(╥﹏╥)o, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220516/1a2ff9f326a0477e8204130614c6ca41/2464af203a674379ae82ed8b1b25b04a.jpg, createdBy=b4f82193754, createdName=congratulation 123, createdTime=Sat Sep 14 16:14:14 CST 2024, time=2024-09-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206850, encodeId=9835220685019, content=请问拒稿重投邮件都写的是什么啊，We appreciate you considering Advanced Science and regret that we are unable to provide a more positive outcome at this stage, but we hope the reviewer comments will help you to improve your manuscript for resubmission to Advanced Science. 我也不确定这是不是拒稿重投，但投稿系统确实是拒稿了~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=650b5421607, createdName=SCI小青椒, createdTime=Mon May 27 14:26:15 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2218556, encodeId=23ab22185563d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：两正一负意见，拒稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72939412153, createdName=ms1000001167055324, createdTime=Mon Aug 05 14:11:46 CST 2024, time=2024-08-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230217, encodeId=11ee223021eb8, content=偏重的研究方向：医学;基础研究;肠道菌群 经验分享：想请问一下拒稿重投的接受可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Thu Oct 10 20:14:53 CST 2024, time=2024-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2251519, encodeId=cab42251519f4, content=请问有友友是被拒稿申诉以后给大修机会的吗，中稿的机会大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6829440210, createdName=ms2000000449821444, createdTime=Tue Feb 11 21:51:51 CST 2025, time=2025-02-11, status=1, ipAttribution=江苏省)]

2025-02-11 ms2000000449821444 来自江苏省

请问有友友是被拒稿申诉以后给大修机会的吗，中稿的机会大吗

27 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务